Magnus Group is pleased to announce one of its kind “2nd International conference on Orphan Drugs and Rare Diseases” during March 17-19, 2025 at Rome, Italy. Orphan Drugs 2025 is scheduled in Hybrid Format: You can participate Hybrid from your home or workplace.
This Hybrid mode allows you to participate as in-person in Rome, Italy or Virtual from your home or work.
The conference will maintain its unique theme “Orphan drugs: Ray of hope for rare disease”.
A rare disease is described by the World Health Organization as a disease or disorder that affects one in every 1000 people. However, rare diseases are not so rare these days. These diseases have grabbed the attention of the pharmaceutical industry and scientists over the past three decades.
Orphan drugs are medications or vaccines that are used to treat, prevent, or diagnose a rare disorder (such as Huntington's disease, Tourette syndrome or myoclonus). These drugs are called orphan because of their rarity, without government funding it would be unprofitable to manufacture these drugs. Orphan drug production for rare diseases is rife with opportunities and obstacles on a global scale, including regulatory strategies, research and development, clinical trials, time to reach market, and affordability and accessibility disparities. It is timely that experts from academia and industry unite and address these issues that will steer the development of orphan drugs.
This global congress on Orphan drugs and rare diseases provides a head interdisciplinary stage for experts to introduce their most recent research findings and portray developing advances and bearings in rare diseases. Orphan Drugs 2025 attempts to contribute to presenting novel research results in all aspects of Orphan Drugs and Rare Diseases and address the hardships faced by the scientific community from its development to its marketing.
This Congress will bring experts from the whole value chain under one roof, where you get to meet decision-makers in the areas of your interest and collaborate with them for future research. The conference aims to bridge the gap between industry and academia by uniting biotechnologists, scientists, researchers, doctors, orphan drug developers, professors, research organizations, experts from pharma industry, startups and key players in the industry.
Upcoming Orphan Drugs Conferences: Orphan Drugs Conferences 2025 | Rare Diseases Conferences | Orphan Drugs Congress | Rare Diseases Conferences 2025
Get news, updates, and more from the Conference.
Upcoming Conferences
Conference Name | Dates | Venue |
2nd International conference on Orphan Drugs and Rare Diseases | March 17-19, 2025 | Rome, Italy |
International conference on Orphan Drugs and Rare Diseases | August 17-18, 2023 | Online Report:
Magnus Group has successfully concluded the Virtual International Conference on Orphan Drugs and Rare Diseases, which took place on August 17-18, 2023.
Throughout the conference, we remained committed to our unique theme, "Orphan Drugs: Ray of Hope for Rare Diseases."
Although the World Health Organization characterizes rare diseases as affecting one in every 1000 people, their prevalence is becoming more evident. Over the last three decades, rare diseases have captured considerable interest from both the pharmaceutical industry and scientific communities.
For Orphan Drugs 2023 Final Program: Click Here
For Orphan Drugs 2023 Abstract Book: Click Here
Recommended: Orphan Drugs Conferences 2025 | Rare Diseases Conferences | Orphan Drugs Congress | Rare Diseases Conferences 2025
Keynote Presenters:
Daniel Scherman from Foundation for Rare Diseases, France
Vivek Gupta from St. John’s University, United States
Harsha K. Rajasimha from Jeeva Informatics Solutions Inc, United States
Oral Presenters:
Juan He from Shanghai JiaoTong University School of Medicine, China
Jiao Fuyong from Shaanxi Provincial People’s Hospital, China
Fereshteh Sedaghat from Aristotle University, Greece
Magali Taiel from GenSight Biologics, France
J. Somasekar from Jain University, India
Angel Cuesta from Complutense University of Madrid, Spain
Kondakova O. B from National Medical Research Center for Children's Health, Russian Federation
Kranthi Kumar Singamaneni from Alliance College of Engineering and Design, India
Priyanka Wadhwa from Ikris Pharma Network, India
Arti Sharma from Govt. P.G. College Prithvipur, India
Zeynep Unluturk from University of Health Sciences Kocaeli Derince Training Hospital, Turkey
Vicki Ratner from International Society for the Study of BPS, United States
Paul L. Kaufman from University of Wisconsin-Madison, United States
Poster Presenters:
Huaixiu Wang from Shaanxi Provincial Hospital, China
Drake Carter from Rosalind Franklin University of Medicine and Science, United States
Daniel Wainstock from Georgetown University, Brazil
Recommended: Orphan Drugs Conferences 2025 | Rare Diseases Conferences | Orphan Drugs Congress | Rare Diseases Conferences 2025
I enjoyed meeting with many of the attendees.
I did enjoy meeting so many people from different countries with great ideas.
I did thoroughly enjoy the Conference. It was a refreshing and inspiring meeting for me to hear about so much Nursing research being done.
The conference was simple fantastic. The topics, speakers, and especially the sharing with nurses and healthcare workers from around the world. The interaction with all people was so inspirational.
The conference was organized very well. I very much appreciated the fact that speakers were kept on time. I enjoyed the sessions.